600594.SH
益佰制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.09
+9.95%Margins
Gross margin
59.2%
EBITDA margin
-6.9%
EBIT margin
-18.3%
Net margin
-20.3%
FCF margin
15.0%
-16.2%
Return on equity
-10.3%
Return on assets
-11.5%
Return on invested capital
0.50x
Asset turnover
CNY 294.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026